SCHEMBL7112333

SCHEMBL7112333

O=C1Cc2ccccc2Oc2cc(O)c(O)c(O)c21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.48
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
LDHA P00338 1/20 0.41
LDHB P07195 1/20 0.41
TOP1 P11387 1/20 0.38
TOP2A P11388 1/20 0.38
BCL2 P10415 1/20 0.38
MCL1 Q07820 1/20 0.38
POLB P06746 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
PRKCG P05129 1/20 0.35
PRKCA P17252 1/20 0.35
PRKCD Q05655 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
ACSL1 P33121 1/20 0.34
ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14098172 0.84 PLK1 (0.45) PLK1MAOAMAOBLDHALDHB
SCHEMBL7117517 0.82 MAOA (0.43) PLK1MAOAMAOBLDHALDHB
SCHEMBL7110722 0.82 CYP19A1 (0.48) MAOAMAOBPOLBALDH1A1MEN1
SCHEMBL7112833 0.78 MAOA (0.50) PLK1MAOAMAOBLDHALDHB
SCHEMBL7114519 0.78 LDHA (0.43) PLK1MAOAMAOBLDHALDHB
SCHEMBL7110710 0.76 MAOA (0.47) MAOAMAOBTOP1TOP2AALDH1A1
SCHEMBL7115723 0.76 ABCG2 (0.53) MAOAMAOBABCG2ALDH1A1MAPT
SCHEMBL7115666 0.72 GAA (0.44) MAOAMAOBPOLBABCG2NPC1
SCHEMBL7112829 0.71 ALDH1A1 (0.49) MAOAMAOBPOLBNPC1RAB9A
SCHEMBL57888 0.70 MAOA (0.62) MAOAMAOBNPC1RAB9AACSL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065021-A1 Tracheal smooth muscle relaxants YAMASHITA SHINYA (JP) 2003-04-03 US disclosed
US-6495592-B1 DIBENZ(B,F)OXEPIN DERIVATIVES; ANTIASTHMATICS NIPPON SUISAN KAISHA, LTD. (JP) 2002-12-17 US disclosed
EP-0805155-B1 NOVEL ANTIOXIDANT TRICYCLIC FUSED HETEROCYCLIC COMPOUND NIPPON SUISAN KAISHA LTD (JP) 2002-03-13 EP disclosed
US-6180659-B1 USING A DIBENZO(B,F)-(OXEPIN OR THIEPIN) COMPOUND NIPPON SUISAN KAISHA, LTD. (JP) 2001-01-30 US disclosed
EP-0885610-A1 TRACHEAL SMOOTH MUSCLE RELAXANT NIPPON SUISAN KAISHA, LTD. (JP) 1998-12-23 EP disclosed
EP-0805155-A1 NOVEL ANTIOXIDANT TRICYCLIC FUSED HETEROCYCLIC COMPOUND NIPPON SUISAN KAISHA, LTD. (JP) 1997-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065021-A1 Tracheal smooth muscle relaxants MYLK, MUSK, CPT1B PLK1 4582/4885MAOA 2385/4885MAOB 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.